Clinical Trial Update: Dose Escalation Trial of Neoadjuvant Sorafenib and Concurrent Sorafenib, Cisplatin and Radiation in Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN) [Phase 1]

View source ↗

Summary

A Phase 1 dose-escalation trial of neoadjuvant sorafenib with cisplatin and radiation for locally advanced head and neck squamous cell carcinoma has been withdr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Nexavar (Sorafenib)

Snippet

Sponsor: British Columbia Cancer Agency | Conditions: Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN) | Phase 1 | Status: WITHDRAWN